Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on April 7, 2025

Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
SAN DIEGO and SUZHOU, China, April 07, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chairman, Chief Executive …

Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus’ Directors and Promote a Flawed Strategy Urges Stockholders to Vote on the BLUE Proxy Card FOR All Nine of the Company’s Nominees RESEARCH TRIANGLE PARK, N.C., April 07, …

Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology
FLORHAM PARK, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced a key publication in the April 4, 2025, issue of the prestigious peer- …

Vital Battery Metals Announces Letter of Intent to Acquire the Corvo Uranium Project in the Athabasca Basin
Corvo Uranium Project Highlights More than 29 km of exploration strike length along three strong NE-SW magnetic low trends coincident with EM conductors and cross-cutting faults, providing highly prospective shallow drill targets. Uranium mineralization is …

Diamond Equity Research Initiates Coverage on Almonty Industries, Inc. (TSX: AII) (ASX: AII) (FWB: ALI) (OTCQX: ALMTF)
New York, NY, April 07, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Almonty Industries, Inc. (TSX: AII) (ASX: AII) (FWB: ALI) (OTCQX: ALMTF …

CareCloud to Present at the LD Micro Invitational XV
SOMERSET, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, is pleased to …

Telesat secures substantial multi-year contract with Viasat for Telesat Lightspeed services
OTTAWA, Ontario, April 07, 2025 (GLOBE NEWSWIRE) -- Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, today announced that Viasat Inc. has signed a substantial multi-year contract for Telesat Lightspeed Low …

Aspargo Labs Expands Global Leadership Team
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in …

Libraries Offering Brain Exercises Can Become Centers for Brain Health
SAN FRANCISCO, April 07, 2025 (GLOBE NEWSWIRE) -- Libraries have long been centers for knowledge and learning, but now that libraries frequently offer free access to online apps, many libraries are taking a further step to become centers for brain health. …

Dundee Precious Metals Annual and Special Meeting of Shareholders to be held May 7, 2025
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces its Annual and Special Meeting of Shareholders will be held on Wednesday, May 7, 2025, at 4 PM EDT via live audio webcast. Materials for …

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pediatric patients, addressing the high unmet need for …

Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses at the Anxiety & Depression Association of America (ADAA) 2025 Conference
-- AjD is a Mental Health Condition Triggered By a Stressful Life Event; Particularly Common in People with Serious Medical Illness -- -- AjD Represents an Area of Significant Unmet Need; No FDA-Approved Therapies Currently Available -- -- Expansion of …

Bombardier to Report First Quarter 2025 Financial Results and Hold Annual General Meeting of Shareholders on May 1st, 2025
MONTREAL, April 07, 2025 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2025 on May 1st, 2025. That same day, Bombardier will hold its Annual General Meeting of Shareholders (“Meeting”) in a virtual …

Bombardier présentera ses résultats financiers du premier trimestre de 2025 et tiendra son assemblée générale annuelle des actionnaires le 1er mai 2025
MONTRÉAL, 07 avr. 2025 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) publiera ses résultats financiers du premier trimestre de 2025 le 1er mai 2025. Le même jour, Bombardier tiendra son assemblée générale annuelle des actionnaires (« Assemblée ») en format …

Sulliden Acquires Portion of Nickel, Zinc, and Lead Mining Exploration Project in Poland
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Sulliden Mining Capital Inc. (“Sulliden” or the “Company”) (TSX: SMC) is pleased to announce that it has indirectly acquired a 5.2% interest in a nickel, zinc, and lead mining exploration project in Poland (the “ …

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
DUBLIN, Ireland and BRIDGEWATER, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Michael Torok, Co-Founder and Managing Director of investment firm JEC Capital Partners, as a member of the …

Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
Bridging Science and Clinical Practice: A Gathering of Thought Leaders in Cannabinoid Medicine Live and Virtual Symposium on June 6th, 2025, at the MaRS Discovery District, Toronto TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or …

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis (MS) and the other detailing the experience of …

Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer
WALTHAM, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …

Kraig Biocraft Laboratories is Happy to Announce its New Director of Molecular Biology as it Accelerates Advanced Fibers Development
ANN ARBOR, Mich., April 07, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk-based super materials, is pleased to announce the appointment of Dr. Xiaoli Zhang as Director of …